scholarly journals The Clinical Efficacy of Azathioprine in Korean Patients with Atopic Dermatitis

2015 ◽  
Vol 27 (6) ◽  
pp. 774 ◽  
Author(s):  
Hemin Lee ◽  
Jung U Shin ◽  
Kwang Hoon Lee
Keyword(s):  
Atopic Dermatitis ◽  
Clinical Efficacy ◽  
Korean Patients

scholarly journals Change in Antimicrobial Susceptibility of Skin-Colonizing Staphylococcus aureus in Korean Patients with Atopic Dermatitis during Ten-Year Period

2016 ◽  
Vol 28 (4) ◽  
pp. 470 ◽  
Author(s):  
Jung-Min Park ◽  
Ju-Hyun Jo ◽  
Hyunju Jin ◽  
Hyun-Chang Ko ◽  
Moon-Bum Kim ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Atopic Dermatitis ◽  
Antimicrobial Susceptibility ◽  
Korean Patients

The Clinical Efficacy of a Multi-Lamellar Emulsion Containing Pseudoceramide in Childhood Atopic Dermatitis: An Open Crossover Study

2003 ◽  
Vol 15 (4) ◽  
pp. 133 ◽  
Author(s):  
Eun Ju Lee ◽  
Ki Beom Suhr ◽  
Jeung Hoon Lee ◽  
Jang Kyu Park ◽  
Chun Yu Jin ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Crossover Study ◽  
Clinical Efficacy ◽  
Open Crossover

scholarly journals Economic Impact of Atopic Dermatitis in Korean Patients

2015 ◽  
Vol 27 (3) ◽  
pp. 298 ◽  
Author(s):  
Chulmin Kim ◽  
Kui Young Park ◽  
Seohee Ahn ◽  
Dong Ha Kim ◽  
Kapsok Li ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Economic Impact ◽  
Korean Patients

Clinical efficacy of neural therapy for the treatment of atopic dermatitis in dogs

2008 ◽  
Vol 56 (4) ◽  
pp. 459-469 ◽  
Author(s):  
Adriana Bravo-Monsalvo ◽  
Juan Vázquez-Chagoyán ◽  
Lilia Gutiérrez ◽  
Héctor Sumano
Keyword(s):  
Atopic Dermatitis ◽  
Clinical Efficacy ◽  
Severity Index ◽  
Control Group ◽  
Matched Pairs ◽  
Neural Therapy ◽  
Canine Atopic Dermatitis ◽  
Dermatological Condition ◽  
Before And After ◽  
History Of

The aim of this trial was to assess the clinical efficacy of neural therapy (NT) when treating canine atopic dermatitis. Eighteen dogs (no control group), with at least a 12-month history of having nonseasonal atopic dermatitis, were included. No medication with either glucocorticoids or cyclosporin was allowed during the trial. One set of NT was given by injecting an intravenous dose of 0.1 mg/kg of a 0.7% procaine solution, followed by 10 to 25 intradermal injections of the same solution in a volume of 0.1–0.3 mL per site. Dogs were given 6–13 sets of NT during the therapy. The dermatological condition of each patient was evaluated before and after the treatment using two scales: the pruritus visual analogue scale (PVAS) and the canine atopic dermatitis extent and severity index (CADESI). The reduction of pruritus was statistically significant using a Wilcoxon matched-pairs signed-ranks test (P < 0.001). No adverse side effects were observed. NT seems to be an effective alternative to control signs related to canine atopic dermatitis.

Sign in / Sign up

Export Citation Format

Share Document